ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

CD47/SIRPα Signaling Controls TLR4-Driven Inflammatory Response via Regulating the Akt-β-Catenin Axis in Mesenchymal Stem Cell (MSC)-Mediated Immune Regulation in Liver Ischemia and Reperfusion Injury

M. Sheng, Y. Lin, C. Li, Y. Tian, D. Xu, Y. Zhan, A. J. Coito, D. G. Farmer, R. W. Busuttil, J. W. Kupiec-Weglinski, B. Ke

Surgery, Dumont - UCLA Transplant Ctr, Los Angeles, CA

Meeting: 2020 American Transplant Congress

Abstract number: 537

Keywords: Immunosuppression, Inflammation, Liver, Stem cells

Session Information

Date: Saturday, May 30, 2020

Session Name: Cellular Therapies, Tissue Engineering / Regenerative Medicine

Session Time: 3:15pm-4:45pm

 Presentation Time: 4:03pm-4:15pm

Location: Virtual

Related Abstracts
  • PGE2/Beta-Catenin/XBP1 Signaling Controls Mesenchymal Stem Cell-Mediated Immune Regulation in Liver Ischemia and Reperfusion Injury
  • Hyperglycemia-Triggered ATF6-CHOP Pathway Exacerbates Liver Ischemia/Reperfusion Injury: Immunomodulation by Regulating β-Catenin Signaling

*Purpose: Innate immune-driven local inflammation induced by ischemia/reperfusion injury (IRI) causes hepatic dysfunction and failure following liver transplantation. Although mesenchymal stem cell (MSC)-based therapy has been successfully applied in various human diseases, a number of clinical phase III trials of MSC immunotherapy failed to meet the primary endpoints because of the low efficacy of engrafted cells. CD47/SIRPα signaling has been implicated in regulating innate immunity during inflammatory response. This study was designed to enhance the immunosuppressive ability of MSC by dissecting the functional roles and molecular mechanisms of the CD47/SIRPα signaling in MSC-mediated immune regulation during liver IRI.

*Methods: Using a mouse liver IR injury model, the myeloid-specific β-catenin knockout (β-cateninM-KO) and β-catenin-proficient (β-cateninFL/FL) mice were i.v. injected with MSCs (1×106) 24h prior to liver ischemia. Mice were sacrificed after 6h of reperfusion. For in vitro study, MSCs were transfected with CRISPR/Cas9-mediated CD47 knockout (KO) or control vector, and then co-cultured with bone marrow-derived macrophages (BMMs) followed by LPS stimulation.

*Results: Adoptive transfer of MSCs ameliorated IR-induced liver damage as evidenced by reduced sALT levels and histological Suzuki’s scores, diminished macrophage/neutrophil accumulation and inflammatory mediators. MSC treatment augmented CD47, signal regulatory protein alpha (SIRPα), and β-catenin but reduced Foxo1 and TLR4 expression in ischemic livers. However, disruption of myeloid β-catenin in MSC-transferred mice exacerbated liver IRI with augmented Foxo1 and TLR4 activity. Using a MSC/macrophage co-culture system, increased MSC CD47 and macrophage SIRPα expression were found after LPS stimulation. MSC increased SIRPα, p-Akt, and β-catenin expression in LPS-stimulated macrophages. However, CD47 KO in MSC reduced macrophage p-Akt and β-catenin but enhanced Foxo1 and TLR4 activity after co-culture. Moreover, disruption of macrophage β-catenin reduced M2 macrophage Arg1 and augmented M1 macrophage iNOS with increased proinflammatory TNF-α, IL-β, and MCP-1 expression even co-cultured with MSC.

*Conclusions: MSC promotes CD47/SIRPα interaction, which in turn modulates the Akt-β-catenin axis leading to diminished Foxo1/TLR4 activity in IR-triggered liver inflammation. Our findings may provide novel therapeutic strategies to treat transplant recipients using genetically modified MSC approaches or pharmacological interventions targeting the CD47/SIRPα signaling in the donor or in the graft before implantation or reperfusion.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Sheng M, Lin Y, Li C, Tian Y, Xu D, Zhan Y, Coito AJ, Farmer DG, Busuttil RW, Kupiec-Weglinski JW, Ke B. CD47/SIRPα Signaling Controls TLR4-Driven Inflammatory Response via Regulating the Akt-β-Catenin Axis in Mesenchymal Stem Cell (MSC)-Mediated Immune Regulation in Liver Ischemia and Reperfusion Injury [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/cd47-sirp%ce%b1-signaling-controls-tlr4-driven-inflammatory-response-via-regulating-the-akt-%ce%b2-catenin-axis-in-mesenchymal-stem-cell-msc-mediated-immune-regulation-in-liver-ischemia-and-reperfus/. Accessed March 4, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.